Their focus on growth-hormone peptide stacks (CJC-1295, Ipamorelin, Sermorelin) aligns well with the most in-demand peptide categories in 2026
Intravenous (IV) or Intramuscular (IM) Glutathione In response to oral glutathiones above limitations, alternative delivery methods like intravenous and intramuscular injections have been explored
However, research on ipamorelin is limited and the FDA has not approved it yet
PPOs may cover GLP-1 medications, but you might face higher copays or coinsurance
Multiple new GLP-1 agents in development (retatrutide, oral tirzepatide, oral semaglutide for weight loss) will increase market options and may pressure prices
The GLP-1 mechanism works through the same hormonal pathways your body already uses to regulate hunger, which is why the appetite reduction tends to feel natural rather than forced